-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

203.O2.6 203. Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections: T and B Lymphocyte Biology

Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections Program: Oral and Poster Abstracts
Type: Oral
Sunday, December 6, 2015: 4:30 PM-6:00 PM
W315, Level 3 (Orange County Convention Center)
Moderators:
Vicki A Boussiotis, MD, PhD, Harvard Institutes of Medicine, Beth Israel Deaconess Medical Center and Taku Kambayashi, MD/PhD, University of Pennsylvania

Disclosures:
No relevant conflicts of interest to declare.
4:30 PM

Kankana Bardhan, PhD1*, Nikolaos Patsoukis, PhD1*, Duygu Sari1*, Theodore Anagnostou2*, Pranam Chatterjee1*, Gordon J. Freeman, PhD3*, Lequn Li, MD, PhD1* and Vassiliki A. Boussiotis, MD, PhD1

1Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
2Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
3Dana-Farber Cancer Institute, Boston, MA

4:45 PM

Yuhong Chen, Ph.D.1*, Yongwei Zheng, Ph.D.2*, Xiaona You, Ph.D.3*, Gang Xin, Ph.D.1*, Mei Yu, Ph.D.1*, Guoping Fu, Ph.D.1*, Fen Zhou4*, Wen Zhu1*, Weiguo Cui, Ph.D.1*, Jing Zhang, PhD3, Renren Wen, PhD1* and Demin Wang, PhD1

1Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, WI
2Blood Research Institute, Bloodcenter of Wisconsin, Milwaukee, WI
3McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI
4Department of Pediatrics, Union Hospital, Tongji Medical College, Wuhan, China

5:00 PM

Chun Yang, M.D. Ph.D.1,2*, Jianhong Lin, M.D, M.Sc1*, Hongyan Liang, M.D. Ph.D.2*, Ariel Kwart, B.S.1*, Meng Jiang, M.D1*, Jianjun Zhao, M.D. Ph.D.1, Xiaofeng Jiang, M.D. Ph.D.2* and Nikhil C. Munshi, MD3,4

1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
2Department of Clinical Laboratory, the 4th Hospital of Harbin Medical University, Harbin, China
3Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Boston, MA
4VA Boston Healthcare System, West Roxbury, MA

5:15 PM

Matthew S Beatty, PhD1*, Rebecca S Hesterberg, BA2, Ying Han, MD3*, Eric Padron, M.D.1,4, Adam W Mailloux, PhD1*, Sean Yoder, M.S5*, Anjali M Rajadhyaksha, PhD6*, Alan F. List, MD7,8 and Pearlie K Epling-Burnette, PhD1

1Department of Immunology, Moffitt Cancer Center and Research Institute, Tampa, FL
2Immunology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
3Biotherapy Department, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
4Division of Hematologic Malignancies, Moffitt Cancer Center and Research Institute, Tampa, FL
5Molecular Genomics Core Facility, Moffit Cancer Center and Research Institute, Tampa, FL
6Pediatric Neurology, Weill Cornell Medical College, New York, NY
7Department of Hematologic Malignancies, Moffitt Cancer Center and Research Institute, Tampa, FL
8Division of Clinical Science, Moffitt Cancer Center and Research Institute, Tampa, FL

5:30 PM

Marcin Lyszkiewicz, PhD1,2*, Jonas Blume, PhD1*, Natalia Zietara, PhD1,2*, Katrin Witzlau1*, Jacek Puchalka, PhD2*, Namita Saran, PhD3,4*, Sandra Duber, PhD5*, Roy Bishnudeo, PhD5,6*, Siegfried Weiss, PhD7* and Andreas Krueger, PhD, Prof.1*

1Institute of Immunology, Hannover Medical School, Hannover, Germany
2Dr. von Hauner Children's Hospital, Ludwig Maximilians University, Munich, Germany
3Hannover Medical School, Hannover, Germany
4Immunobiology, King's College London, London, United Kingdom
5Molecular Immunology, Helmholtz Centre for Infection Research, Braunschweig, Germany
6Centre for Immune Regulation and Department of Immunology, University of Oslo and Oslo University Hospital, Oslo, Norway
7Molecular Immunology, Helmholtz Centre for Infection Research, HZI, Braunschweig, Germany

5:45 PM

Adam T. Utley, BS, BA1*, Daniela Ventro, PhD1*, Megan Murray, MD, PhD2*, Amin Mahpour, BS, MS3* and Kelvin P. Lee, MD4

1Immunology, Roswell Park Cancer Institute, Buffalo, NY
2Duke University, Durham, NC
3Roswell Park Cancer Institute, Buffalo, NY
4Departments of Medicine and Immunology, Roswell Park Cancer Institute, Buffalo, NY

*signifies non-member of ASH